NCT01508091

Brief Summary

Calorie restriction is the only experimental manipulation that prolongs longevity in experimental animals. The life prolonging effects of calorie restriction are related to a lower incidence of tumors and less inflammation, but more importantly, a lower generation of reactive oxygen species (ROS). This effect is related to the overexpression of two groups of enzymes. One is a group of (NAD+)-dependent deacetylases called sirtuins whose main actions are to increase free fatty acid flow from adipose tissue, improve insulin secretion and promote mitochondrial biogenesis in muscle. The other group corresponds to uncoupling proteins (UCP), specially UCP 3 that reduces the mitochondrial production of ROS. On the other hand, an effect of calorie restriction that is always reported, is a decrease in resting energy expenditure. A reduction in the activity of UCP1 in brown adipose tissue could be a mechanisms to explain this effect. However sirtuins apparently increase the expression of UCP1.Recently PET CT scans have emerged as a non invasive methodology to recognize brown adipose tissue activity and indirectly, UCP1 activity. Also measurement of telomere length in peripheral blood mononuclear cells has consolidated as a good marker of aging. Two possible models of calorie restriction can be studied in humans. One is a retrospective model in which adults are separated in those that have maintained a stable weight during adulthood in a manner analogous to the weight clamp model of calorie restriction in non human primates. This model is only reliable if there are objective records of the weight that the studied subjects had 20 or more years ago. In the retrospective part of this project the investigators propose to study adults whose weight was recorded previously. The investigators pretend to compare telomere length and expression of SIRT1 and 6 in PBMC, plasma 8 isoprostanes and carotid intima media thickness between weight maintainers and weight gainers. The investigators hypothesis is that weight maintainers will have a better aging profile than weight gainers. In the prospective part of the project the investigators will study a human model of calorie restriction prescribing a 25% reduction in calorie intake during 3 months and comparing groups according to weight loss. At baseline and the end of the study period, UCP3 and SIRT1 expression in muscle biopsies, SIRT1 and 6 expression in PBMC and brown adipose activity, assessed by 18fluorodeoxyglucose uptake using PET/CT will measured. The investigators hypothesis is that individuals subjected to calorie restriction will experience an increase in the expression of UCP3, SIRT1 and SIRT6 and a reduction in brown adipose tissue activity. Simultaneously, these subjects will experience a reduction in oxidative stress markers in muscle and plasma.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started May 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 11, 2012

Completed
4 months until next milestone

Study Start

First participant enrolled

May 1, 2012

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

October 23, 2012

Status Verified

October 1, 2012

Enrollment Period

7 months

First QC Date

January 6, 2012

Last Update Submit

October 20, 2012

Conditions

Keywords

Obesityageing

Outcome Measures

Primary Outcomes (1)

  • UCP3 mRNA expression in vastus lateralis after energy restriction

    The main outcome measure will be UCP3 mRNA expression in vastus lateralis, which will be measured before and after the 3 month intervention period. This enzyme is the last link in the chain of events that occur after calorie restriction. Millet et al reported a value for UCP3 mRNA of 15 ± 1.5 amol/ìg total RNA in 18 subjects. Expecting a 60% increase over baseline in the expression of the enzyme, 17 subjects per group are required to obtain results with an á of 0.05 and a power of 0.8. Considering attrition rates, we must study 24 subjects per group.

    3 months

Secondary Outcomes (1)

  • Brown adipose tissue (BAT) activity, indicating UCP1 expression after calorie restriction

    3 months

Study Arms (1)

Calorie restricted

EXPERIMENTAL

25 % calorie restriction respect measured total energy expenditure, using a Mediterranean diet

Behavioral: energy restricted mediterranean-type dietBehavioral: 25 % calorie restriction

Interventions

Prescription of diet 25 % lower than actual total energy expenditure in overweight or moderately obese premenopausal women

Also known as: Calorie restriction, Energy restriction, Mediterranean diet
Calorie restricted

25 % calorie restriction respect total energy expenditure

Calorie restricted

Eligibility Criteria

Age25 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • overweight or obese premenopausal women aged 25 - 40 years

You may not qualify if:

  • diabetes,
  • chronic diseases,
  • extreme physical exercise,
  • drugs affecting energy expenditure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica Alemana de Santiago

Santiago, Santiago Metropolitan, Chile

RECRUITING

MeSH Terms

Conditions

Obesity

Interventions

Caloric RestrictionDiet, Mediterranean

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaDiet, Plant-Based

Central Study Contacts

Maria Pia de la Maza, MD

CONTACT

Daniel Carlos Bunout, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 6, 2012

First Posted

January 11, 2012

Study Start

May 1, 2012

Primary Completion

December 1, 2012

Study Completion

June 1, 2013

Last Updated

October 23, 2012

Record last verified: 2012-10

Locations